koko体育app

欢迎来到《koko体育app 学报(医学版)》
段婷婷, 初金语, 胡斐斐. 单细胞转录组鉴定阿尔茨海默病外周血生物标志物GZMK+ CD8+ T细胞[J]. koko体育app 学报(医学版), 2023, 54(5): 863-873. DOI:
引用本文: 段婷婷, 初金语, 胡斐斐. 单细胞转录组鉴定阿尔茨海默病外周血生物标志物GZMK+ CD8+ T细胞[J]. koko体育app 学报(医学版), 2023, 54(5): 863-873. DOI:
DUAN Tingting, CHU Jinyu, HU Feifei. Identification of Peripheral Blood GZMK+ CD8+ T Cells As Biomarkers of Alzheimer's Disease Based on Single-Cell Transcriptome[J]. Journal of Sichuan University (Medical Sciences), 2023, 54(5): 863-873. DOI:
Citation: DUAN Tingting, CHU Jinyu, HU Feifei. Identification of Peripheral Blood GZMK+ CD8+𒁃 T Cells As Biomarkers of Alzheimer's Disease Based on Single-Cell Transcriptome[J]. Journal of Sichuan University (Medical Sciences), 2023, 54(5): 863-873. DOI:

单细胞转录组鉴定阿尔茨海默病外周血生物标志物GZMK+ CD8+ T细胞

Identification of Peripheral Blood GZMK+ CD8+ T Cells As Biomarkers of Alzheimer's Disease Based on Single-Cell Transcriptome

  • 摘要:
      目的  基于单细胞RNA测序(single cell RNA sequencing, scRNA-seq)挖掘阿尔茨海默病(Alzheimer's disease, AD)外周血免疫特征作为生物标志物,系统性探索AD外周血免疫细胞亚型丰度、基因表达特征和细胞通讯异常。
      方法  从GEO数据库中下载AD外周血免疫细胞scRNA-seq数据集GSE168522,于RAD-Blood网页服务器()中分析AD患者血液细胞组成成分变化,利用CellChat分析AD患者血液中异常的细胞间通讯作用。
      结果  AD患者和健康人血液中有两种CD8+ T细胞,其中一类高表达颗粒酶K(granzyme K, GZMK)〔伪发现率(false discovery rate, FDR)<0.05〕,另一类高表达GZMAGZMBGZMH(FDR<0.05)。GZMK+ CD8+ T细胞在AD患者血液中含量升高32.9%(P=5.15E-21),与其他细胞类型的交互作用增加,并可能通过主要组织相容性复合体Ⅰ类(major histocompatibility complex class Ⅰ, MHC-Ⅰ)信号转导异常与AD关联,红细胞为GZMK+ CD8+ T细胞MHC-Ⅰ信号通路异常提供了主要配体,即人类白细胞抗原(human leukocyte antigen, HLA)Ⅰ类分子(HLA-AHLA-BHLA-CHLA-E)。血液RESISTIN信号通路仅富集于AD患者血液中,其可能是AD血液特异性信号通路。
      结论  外周血GZMK+ CD8+ T细胞含量升高、GZMK+ CD8+ T细胞与红细胞的交互作用增加、RESISTIN通路增强是潜在的AD标志物。
     
    Abstract:
      Objective  Based on single-cell RNA sequencing (scRNA-seq) to explore immune characteristics in the peripheral blood of patients with Alzheimer's disease (AD) as biomarkers.
      Methods  GSE168522, the scRNA-seq dataset of AD peripheral blood immune cells, was downloaded from the Gene Expression Omnibus (GEO) database and was analyzed in the RAD-Blood web server (). The changes in blood cell composition in AD patients were analyzed. The abnormal communications between different types of cells in AD patients were investigated by the CellChat R package.
      Results  There were two kinds of CD8+ T cells in the blood of AD patients and healthy individuals, one of which highly expressed granzyme K (GZMK) (false discovery rate FDR<0.05), and the other highly expressed GZMA, GZMB, and GZMH (FDR<0.05). In the blood of AD patients, the content of GZMK+ CD8+ T cells was increased by 32.9% (P=5.15E-21), their interactions with other cell types were increased, and they might be associated with AD through the abnormal signal transduction of major histocompatibility complex class Ⅰ (MHC-Ⅰ). Erythrocyte provided the main ligands, that are, human leukocyte antigen (HLA) class Ⅰ molecules, including HLA-A, HLA-B, HLA-C, and HLA-E, for the abnormal MHC-Ⅰ signaling pathway of GZMK+ CD8+ T cells. The RESISTIN signaling pathway was specifically enriched in the blood of AD patients.
      Conclusion  The increased content of peripheral blood GZMK+ CD8+ T cells, the increased interaction between GZMK+ CD8+ T cells and erythrocytes, and the enhanced RESISTIN pathway are potential blood biomarkers of AD.
     
© 2023 《koko体育app 学报(医学版)》编辑部 版权所有 cc

开放获取🐈 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问

/

返回文章
返回
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"}); koko体育-koko体育app koko体育-koko体育网页版koko体育app koko体育-全站app下载(官网) m6米乐app|下载 m6米乐app|主頁欢迎您!!